Nuvation Bio Inc.

NUVB

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001811063

SEC filings (opens in a new tab)

In the last 90 days, Nuvation Bio Inc. insiders filed 0 open-market purchases and 1 sale; 244 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; 3 superinvestors hold it, including Duquesne Family Office and Abrams Capital.

Q3 2024 vs. Q2 2024

How the institutions holding Nuvation Bio Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of NUVB: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	148	2	154	+8
Shares	153.1M	16.3M	187.1M	+50.4M (+36.9%)
Value	$447.0M	$47.6M	$428.6M	+$29.2M (+7.3%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Nuvation Bio Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to NUVB in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	16,973,997	$38.9M	0.00%
Frazier Life Sciences Management, L.P.	1,218,236	$2.79M	0.11%
Point72 Asset Management, L.P.	276,714	$633.7K	0.00%
Squarepoint Ops LLC	230,997	$529.0K	0.00%
XTX Topco Ltd	132,029	$302.3K	0.02%
Balyasny Asset Management LLC	95,725	$219.2K	0.00%
ExodusPoint Capital Management, LP	82,447	$189.0K	0.00%
EntryPoint Capital, LLC	79,922	$183.0K	0.10%
Gsa Capital Partners LLP	74,932	$172.0K	0.01%
Quantbot Technologies LP	72,226	$165.4K	0.01%
Cubist Systematic Strategies, LLC	67,002	$153.4K	0.00%
Intech Investment Management LLC	57,856	$132.5K	0.00%
Brevan Howard Capital Management LP	53,632	$122.8K	0.01%
Jump Financial, LLC	33,673	$77.1K	0.00%
Shell Asset Management Co	30,087	$69.0K	0.00%
LPL Financial LLC	24,675	$56.5K	0.00%
Mackenzie Financial Corp	11,346	$26.0K	0.00%
Point72 (DIFC) Ltd	9,495	$21.7K	0.00%
Larson Financial Group LLC	4,000	$9.16K	0.00%
Global Retirement Partners, LLC	1,610	$3.69K	0.00%
Sterling Capital Management LLC	627	$1.44K	0.00%
True Wealth Design, LLC	561	$1.28K	0.00%
Capital Performance Advisors LLP	281	$643	0.00%
Lindbrook Capital, LLC	154	$353	0.00%
HHM Wealth Advisors, LLC	128	$294	0.00%
National Bank of Canada	7	$16	0.00%

Sold out (18)

Institutions that held Nuvation Bio Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of NUVB in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
AWM Investment Company, Inc.	1,350,000	$3.94M
Jacobs Levy Equity Management, Inc	1,281,376	$3.74M
Acadian Asset Management LLC	653,184	$1.91M
BIT Capital GmbH	555,069	$1.62M
Deerfield Management Company, L.P. (Series C)	262,205	$765.6K
Ameriprise Financial Inc	234,030	$683.4K
Franklin Resources Inc	216,814	$633.1K
EAM Investors, LLC	182,876	$534.0K
Thrivent Financial for Lutherans	111,964	$327.0K
Man Group plc	110,626	$323.0K
Public Employees Retirement System of Ohio	108,388	$316.5K
Bayesian Capital Management, LP	46,300	$135.2K
Alpine Global Management, LLC	37,566	$109.7K
Prelude Capital Management, LLC	36,440	$106.4K
Winton Group Ltd	30,350	$88.6K
Nomura Holdings Inc	22,317	$65.2K
AJOVista, LLC	22,295	$65.1K
Pictet Asset Management Holding SA	17,124	$50.0K

Not filed for Q3 2024 yet (2)

Institutions that held Nuvation Bio Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NUVB in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	16,236,764	$47.4M
Susquehanna Fundamental Investments, LLC	76,494	$223.4K